Nex, we studied TYMS and BCL2L1 expression levels in multiple colorectal cancer samples from TCGA, and the results showed that TYMS and BCL2L1 were markedly up-regulated in colorectal cancer patients than normal control (Figs. 2A and 2B). This evidence concerns the gene TYMS and colorectal cancer.